NIFEDIPINE

NIFEDIPINE was reported 41745 times

NIFEDIPINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEOVASCULARISATION 64 0.2433
1 DYSPLASTIC NAEVUS 34 0.0942
2 PHOTODERMATOSIS 39 0.0924
3 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 86 0.0810
4 NEPHROGENIC ANAEMIA 306 0.0660
5 HYPERPARATHYROIDISM SECONDARY 155 0.0618
6 WRIST DEFORMITY 37 0.0602
7 HELLP SYNDROME 36 0.0587
8 GINGIVAL HYPERTROPHY 82 0.0540
9 LOW BIRTH WEIGHT BABY 418 0.0526
10 BLOOD PRESSURE SYSTOLIC ABNORMAL 129 0.0521
11 PRE-ECLAMPSIA 236 0.0496
12 BRASH SYNDROME 69 0.0491
13 POLYDACTYLY 53 0.0457
14 PREMATURE DELIVERY 714 0.0448
15 BLOOD PRESSURE DIASTOLIC ABNORMAL 114 0.0448
16 BRADYCARDIA FOETAL 36 0.0433
17 HYPERTENSIVE EMERGENCY 49 0.0416
18 RENAL ARTERY STENOSIS 55 0.0399
19 JOINT CONTRACTURE 40 0.0373
20 SOLAR LENTIGO 35 0.0369
21 END STAGE RENAL DISEASE 647 0.0354
22 PREMATURE BABY 1049 0.0348
23 FOETAL GROWTH RESTRICTION 210 0.0345
24 BLOOD PRESSURE INADEQUATELY CONTROLLED 193 0.0320
25 REBOUND ACID HYPERSECRETION 91 0.0301
26 APLASTIC ANAEMIA 150 0.0287
27 APGAR SCORE LOW 36 0.0279
28 RECTAL PROLAPSE 33 0.0273
29 SCLERODERMA 98 0.0269
30 BEZOAR 37 0.0268
31 KIDNEY TRANSPLANT REJECTION 128 0.0267
32 NEPHROGENIC SYSTEMIC FIBROSIS 79 0.0261
33 PREMATURE SEPARATION OF PLACENTA 37 0.0240
34 PREMATURE LABOUR 134 0.0237
35 ESSENTIAL HYPERTENSION 43 0.0235
36 OLIGOHYDRAMNIOS 76 0.0228
37 COMPLICATIONS OF TRANSPLANTED KIDNEY 48 0.0211
38 PATENT DUCTUS ARTERIOSUS 84 0.0211
39 SKIN INDURATION 43 0.0207
40 INTRA-UTERINE DEATH 33 0.0205
41 LACUNAR INFARCTION 49 0.0205
42 DIABETIC NEPHROPATHY 45 0.0204
43 NEONATAL RESPIRATORY DISTRESS SYNDROME 72 0.0203
44 CREPITATIONS 60 0.0201
45 SKIN HYPERTROPHY 53 0.0188
46 MEDICATION RESIDUE 47 0.0182
47 PARADOXICAL DRUG REACTION 66 0.0179
48 FOETAL DISTRESS SYNDROME 38 0.0179
49 LEFT VENTRICULAR HYPERTROPHY 76 0.0177
50 ACTINIC KERATOSIS 46 0.0177
51 ATRIOVENTRICULAR BLOCK FIRST DEGREE 76 0.0175
52 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 57 0.0172
53 RETROPERITONEAL HAEMATOMA 38 0.0172
54 VENTRICULAR HYPERTROPHY 43 0.0171
55 OCCULT BLOOD POSITIVE 33 0.0168
56 BLOOD PRESSURE DIASTOLIC DECREASED 122 0.0165
57 PROTEIN URINE PRESENT 79 0.0158
58 RENAL FAILURE CHRONIC 121 0.0157
59 CHRONIC KIDNEY DISEASE 1180 0.0155
60 ARTERIOSPASM CORONARY 62 0.0154
61 BLOOD PRESSURE SYSTOLIC INCREASED 300 0.0154
62 PERIODONTITIS 33 0.0152
63 ORTHOPNOEA 48 0.0151
64 AZOTAEMIA 60 0.0150
65 FOETAL DEATH 77 0.0148
66 BLOOD PRESSURE DIASTOLIC INCREASED 68 0.0147
67 FOETAL EXPOSURE DURING PREGNANCY 1186 0.0146
68 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 36 0.0146
69 ANURIA 122 0.0142
70 RALES 82 0.0141
71 HYPERURICAEMIA 58 0.0141
72 HYPERTENSIVE CRISIS 152 0.0136
73 CAESAREAN SECTION 156 0.0134
74 LEFT VENTRICULAR FAILURE 46 0.0133
75 SHOCK 305 0.0132
76 APLASIA PURE RED CELL 45 0.0131
77 ACUTE PULMONARY OEDEMA 73 0.0130
78 BRAIN NATRIURETIC PEPTIDE INCREASED 40 0.0130
79 PROTEINURIA 246 0.0129
80 ATRIOVENTRICULAR BLOCK SECOND DEGREE 39 0.0128
81 AORTIC ARTERIOSCLEROSIS 33 0.0128
82 TRICUSPID VALVE INCOMPETENCE 101 0.0127
83 PERIPHERAL VASCULAR DISORDER 65 0.0126
84 TUBULOINTERSTITIAL NEPHRITIS 236 0.0126
85 BLOOD UREA INCREASED 210 0.0125
86 RENAL TRANSPLANT 45 0.0124
87 CARDIOMEGALY 153 0.0124
88 BLOOD PRESSURE SYSTOLIC DECREASED 56 0.0123
89 DIASTOLIC DYSFUNCTION 38 0.0123
90 COMPARTMENT SYNDROME 32 0.0123
91 ATRIOVENTRICULAR BLOCK COMPLETE 82 0.0122
92 BLOOD PRESSURE FLUCTUATION 293 0.0122
93 ANGINA UNSTABLE 79 0.0121
94 AORTIC VALVE INCOMPETENCE 51 0.0120
95 PULMONARY HYPERTENSION 249 0.0119
96 HYPERKALAEMIA 417 0.0119
97 PERIPHERAL ISCHAEMIA 48 0.0117
98 CAROTID ARTERY STENOSIS 41 0.0117
99 URINE OUTPUT DECREASED 102 0.0117
100 DIALYSIS 165 0.0116
101 SUSPECTED SUICIDE 54 0.0115
102 DIABETIC NEUROPATHY 57 0.0115
103 RENAL TUBULAR NECROSIS 112 0.0114
104 RENAL INJURY 337 0.0113
105 SKIN TIGHTNESS 53 0.0113
106 ARTERIOSCLEROSIS 106 0.0113
107 LIVE BIRTH 94 0.0112
108 EXPOSURE DURING PREGNANCY 698 0.0112
109 ATRIAL SEPTAL DEFECT 93 0.0111
110 SMALL FOR DATES BABY 55 0.0111
111 FIBROSIS 34 0.0110
112 MATERNAL EXPOSURE DURING PREGNANCY 977 0.0110
113 NEPHROPATHY 102 0.0109
114 RENAL CYST 85 0.0107
115 OLIGURIA 66 0.0106
116 HEPATIC ENZYME ABNORMAL 53 0.0106
117 HYPERLIPIDAEMIA 124 0.0104
118 BUNDLE BRANCH BLOCK LEFT 44 0.0104
119 RENAL FAILURE 1376 0.0104
120 ARTERIOSCLEROSIS CORONARY ARTERY 68 0.0103
121 BLOOD ALBUMIN DECREASED 81 0.0102
122 JOINT RANGE OF MOTION DECREASED 136 0.0101
123 SINUS BRADYCARDIA 98 0.0101
124 RIGHT VENTRICULAR FAILURE 71 0.0101
125 HYPOVOLAEMIA 59 0.0101
126 EXPOSURE VIA BREAST MILK 40 0.0100
127 HAEMODIALYSIS 84 0.0100
128 ACUTE KIDNEY INJURY 1514 0.0099
129 DIABETIC RETINOPATHY 33 0.0097
130 ATRIOVENTRICULAR BLOCK 75 0.0097
131 ILEUS PARALYTIC 43 0.0096
132 INTESTINAL ISCHAEMIA 53 0.0096
133 HYPERKERATOSIS 53 0.0096
134 SQUAMOUS CELL CARCINOMA OF SKIN 58 0.0096
135 BLOOD CREATININE INCREASED 627 0.0096
136 BRADYCARDIA 507 0.0095
137 MYOCARDIAL ISCHAEMIA 108 0.0095
138 CEREBRAL INFARCTION 230 0.0094
139 ISCHAEMIA 43 0.0093
140 CARDIOGENIC SHOCK 134 0.0093
141 RENAL IMPAIRMENT 783 0.0093
142 MITRAL VALVE INCOMPETENCE 105 0.0093
143 PEMPHIGOID 70 0.0093
144 FLUID OVERLOAD 133 0.0091
145 PULMONARY ARTERIAL HYPERTENSION 132 0.0091
146 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 37 0.0091
147 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 92 0.0090
148 BREATH SOUNDS ABNORMAL 44 0.0089
149 HYPERVOLAEMIA 44 0.0089
150 ATELECTASIS 86 0.0089
151 NEPHROTIC SYNDROME 61 0.0089
152 IRON DEFICIENCY 40 0.0089
153 PULMONARY OEDEMA 398 0.0089
154 OEDEMA PERIPHERAL 1076 0.0088
155 HYDRONEPHROSIS 66 0.0088
156 CAROTID ARTERY OCCLUSION 32 0.0088
157 HYPOVOLAEMIC SHOCK 42 0.0088
158 ACUTE MYOCARDIAL INFARCTION 258 0.0087
159 BLOOD POTASSIUM INCREASED 142 0.0087
160 GENERALISED OEDEMA 108 0.0087
161 AORTIC DISSECTION 36 0.0087
162 CARDIAC FAILURE CHRONIC 37 0.0087
163 CARDIAC MURMUR 75 0.0087
164 HYPERTENSION 1835 0.0087
165 METABOLIC ACIDOSIS 277 0.0087
166 NORMAL NEWBORN 47 0.0086
167 CORONARY ARTERY STENOSIS 43 0.0085
168 HAEMODYNAMIC INSTABILITY 65 0.0085
169 HEART RATE DECREASED 299 0.0085
170 BLOOD PRESSURE INCREASED 1300 0.0085
171 DYSLIPIDAEMIA 43 0.0085
172 TENDERNESS 88 0.0084
173 C-REACTIVE PROTEIN ABNORMAL 54 0.0084
174 DYSPNOEA EXERTIONAL 317 0.0084
175 CARDIAC VALVE DISEASE 48 0.0084
176 RESPIRATORY ACIDOSIS 33 0.0084
177 VENTRICULAR SEPTAL DEFECT 48 0.0084
178 LEFT VENTRICULAR DYSFUNCTION 56 0.0084
179 BENIGN PROSTATIC HYPERPLASIA 43 0.0083
180 OEDEMA 446 0.0082
181 TRANSFUSION 86 0.0082
182 PULSELESS ELECTRICAL ACTIVITY 34 0.0081
183 INTERVERTEBRAL DISC DEGENERATION 75 0.0081
184 CORONARY ARTERY DISEASE 245 0.0081
185 GLOMERULAR FILTRATION RATE DECREASED 99 0.0080
186 CEREBRAL ATROPHY 32 0.0080
187 DRUG INTERACTION 1273 0.0080
188 VENTRICULAR FIBRILLATION 89 0.0080
189 RENAL FAILURE ACUTE 338 0.0080
190 MULTI-ORGAN FAILURE 137 0.0079
191 HYPOXIA 279 0.0079
192 MATERNAL DRUGS AFFECTING FOETUS 60 0.0078
193 BODY TEMPERATURE DECREASED 77 0.0078
194 TRANSPLANT REJECTION 62 0.0077
195 VENTRICULAR EXTRASYSTOLES 80 0.0077
196 STILLBIRTH 37 0.0077
197 BUNDLE BRANCH BLOCK RIGHT 35 0.0076
198 BLOOD URIC ACID INCREASED 44 0.0076
199 ECONOMIC PROBLEM 115 0.0076
200 HYPOALBUMINAEMIA 59 0.0076
201 IRON DEFICIENCY ANAEMIA 70 0.0076
202 POLYURIA 62 0.0076
203 HYPOCALCAEMIA 143 0.0075
204 NECROSIS 42 0.0075
205 CARDIAC FAILURE CONGESTIVE 605 0.0075
206 LUNG NEOPLASM 32 0.0075
207 OXYGEN SATURATION DECREASED 421 0.0075
208 MENTAL STATUS CHANGES 208 0.0075
209 SPUTUM DISCOLOURED 71 0.0075
210 ORTHOSTATIC HYPOTENSION 130 0.0075
211 MULTIPLE DRUG OVERDOSE 37 0.0074
212 HYPOTENSION 1493 0.0074
213 DRUG LEVEL INCREASED 123 0.0074
214 DRUG EXPOSURE DURING PREGNANCY 252 0.0074
215 HYPOKALAEMIA 338 0.0073
216 BLOOD POTASSIUM DECREASED 220 0.0073
217 CEREBRAL ISCHAEMIA 37 0.0072
218 BLOOD PRESSURE DECREASED 477 0.0072
219 RENAL DISORDER 334 0.0072
220 HAEMATOCRIT DECREASED 142 0.0072
221 PERICARDIAL EFFUSION 165 0.0071
222 NEUTROPHIL COUNT INCREASED 73 0.0071
223 BLOOD MAGNESIUM DECREASED 61 0.0071
224 FLUID RETENTION 359 0.0071
225 ELECTROLYTE IMBALANCE 82 0.0071
226 SPINAL OSTEOARTHRITIS 62 0.0071
227 CARDIAC FAILURE ACUTE 47 0.0070
228 GANGRENE 42 0.0070
229 NOCTURIA 84 0.0069
230 VITAMIN D DECREASED 59 0.0069
231 VASCULITIS 80 0.0069
232 ANGINA PECTORIS 196 0.0068
233 CORONARY ARTERY OCCLUSION 93 0.0068
234 DIVERTICULUM 48 0.0067
235 ANHEDONIA 177 0.0067
236 SKIN ULCER 174 0.0067
237 CHOLECYSTITIS ACUTE 38 0.0067
238 BLOOD LACTATE DEHYDROGENASE INCREASED 106 0.0067
239 COLITIS ISCHAEMIC 45 0.0067
240 BASAL CELL CARCINOMA 103 0.0066
241 RESPIRATORY DISTRESS 182 0.0066
242 GASTROENTERITIS 96 0.0066
243 RESPIRATORY SYNCYTIAL VIRUS INFECTION 57 0.0065
244 PNEUMONIA BACTERIAL 60 0.0065
245 HYPOMAGNESAEMIA 91 0.0065
246 VENTRICULAR TACHYCARDIA 107 0.0065
247 UPPER GASTROINTESTINAL HAEMORRHAGE 109 0.0065
248 GOUT 116 0.0065
249 SLEEP APNOEA SYNDROME 123 0.0064
250 HEPATOMEGALY 63 0.0064
251 HIATUS HERNIA 83 0.0064
252 COMPLETED SUICIDE 534 0.0064
253 PAIN IN JAW 181 0.0064
254 PLEURAL EFFUSION 387 0.0064
255 LARGE INTESTINE POLYP 44 0.0063
256 PYELONEPHRITIS 55 0.0063
257 OBESITY 101 0.0063
258 PULMONARY CONGESTION 83 0.0063
259 ACIDOSIS 48 0.0063
260 ALTERED STATE OF CONSCIOUSNESS 136 0.0063
261 ELECTROCARDIOGRAM ABNORMAL 49 0.0062
262 CONTRAINDICATED PRODUCT ADMINISTERED 189 0.0062
263 NEPHROPATHY TOXIC 70 0.0062
264 CHOLECYSTITIS 74 0.0062
265 RHINITIS 50 0.0062
266 THERMAL BURN 44 0.0062
267 ILEUS 77 0.0062
268 CARDIAC ARREST 511 0.0062
269 LYMPHOCYTE COUNT DECREASED 109 0.0062
270 LACTIC ACIDOSIS 199 0.0061
271 GASTRITIS 161 0.0061
272 HYPOGLYCAEMIA 296 0.0061
273 HAEMOGLOBIN DECREASED 622 0.0061
274 BLOOD SODIUM DECREASED 114 0.0060
275 CARDIAC FAILURE 484 0.0060
276 BLOOD ALKALINE PHOSPHATASE INCREASED 149 0.0060
277 LOW DENSITY LIPOPROTEIN INCREASED 46 0.0059
278 HYPERGLYCAEMIA 216 0.0059
279 HYPERCALCAEMIA 73 0.0059
280 MYOPATHY 51 0.0059
281 PERIPHERAL COLDNESS 81 0.0059
282 HYPONATRAEMIA 330 0.0059
283 PULMONARY MASS 87 0.0058
284 GASTROOESOPHAGEAL REFLUX DISEASE 470 0.0058
285 CONCOMITANT DISEASE AGGRAVATED 36 0.0058
286 RESPIRATION ABNORMAL 40 0.0058
287 BLOOD PRESSURE ABNORMAL 115 0.0058
288 AORTIC ANEURYSM 44 0.0058
289 SINUS TACHYCARDIA 82 0.0058
290 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 55 0.0058
291 HEPATIC FUNCTION ABNORMAL 215 0.0058
292 VISUAL DISTURBANCE 33 0.0057
293 WHITE BLOOD CELL COUNT INCREASED 220 0.0057
294 LUPUS-LIKE SYNDROME 52 0.0057
295 RESPIRATORY FAILURE 418 0.0057
296 SYNOVITIS 103 0.0057
297 INFUSION SITE ERYTHEMA 48 0.0057
298 PHOTOSENSITIVITY REACTION 94 0.0057
299 DISSEMINATED INTRAVASCULAR COAGULATION 80 0.0057
300 DIZZINESS POSTURAL 55 0.0057
301 ASCITES 166 0.0056
302 HEART RATE IRREGULAR 127 0.0056
303 LARGE INTESTINE PERFORATION 39 0.0056
304 DEPRESSED LEVEL OF CONSCIOUSNESS 220 0.0056
305 ACUTE CORONARY SYNDROME 46 0.0055
306 FLANK PAIN 52 0.0055
307 HYPOTHYROIDISM 177 0.0055
308 THROMBOTIC MICROANGIOPATHY 54 0.0055
309 INTERSTITIAL LUNG DISEASE 268 0.0055
310 TOXIC EPIDERMAL NECROLYSIS 84 0.0055
311 PROTHROMBIN TIME PROLONGED 33 0.0055
312 JOINT EFFUSION 38 0.0055
313 HAEMATURIA 188 0.0055
314 OSTEOARTHRITIS 232 0.0055
315 ASPARTATE AMINOTRANSFERASE INCREASED 289 0.0054
316 LOCALISED INFECTION 131 0.0054
317 LEUKOCYTOSIS 98 0.0054
318 ATRIAL FLUTTER 43 0.0054
319 DIABETES MELLITUS INADEQUATE CONTROL 95 0.0054
320 DRUG ERUPTION 95 0.0054
321 ANAEMIA 1022 0.0054
322 ACUTE RESPIRATORY FAILURE 103 0.0053
323 CARDIOMYOPATHY 79 0.0053
324 PRODUCTIVE COUGH 255 0.0053
325 SCIATICA 85 0.0053
326 RHABDOMYOLYSIS 222 0.0053
327 LUNG INFILTRATION 47 0.0053
328 BLOOD TRIGLYCERIDES INCREASED 94 0.0053
329 PULMONARY FIBROSIS 102 0.0053
330 GASTRIC ULCER 101 0.0053
331 TRANSIENT ISCHAEMIC ATTACK 179 0.0053
332 OSTEOMYELITIS 96 0.0053
333 RESPIRATORY RATE INCREASED 47 0.0053
334 DEHYDRATION 702 0.0053
335 HEMIPARESIS 89 0.0052
336 EYE HAEMORRHAGE 70 0.0052
337 SEASONAL ALLERGY 74 0.0052
338 UROSEPSIS 48 0.0052
339 SMALL INTESTINAL OBSTRUCTION 64 0.0052
340 BRONCHIECTASIS 35 0.0052
341 HAEMOLYSIS 40 0.0052
342 MUCOSAL INFLAMMATION 135 0.0052
343 DECUBITUS ULCER 42 0.0051
344 ACUTE RESPIRATORY DISTRESS SYNDROME 91 0.0051
345 HYPOPHOSPHATAEMIA 38 0.0051
346 BACTERAEMIA 61 0.0051
347 OSTEOPENIA 78 0.0051
348 CEREBRAL HAEMORRHAGE 184 0.0051
349 APNOEA 40 0.0051
350 BLOOD CALCIUM INCREASED 45 0.0051
351 ANOREXIA 66 0.0051
352 TUMOUR LYSIS SYNDROME 45 0.0051
353 DUODENAL ULCER 36 0.0051
354 NERVE COMPRESSION 47 0.0051
355 PNEUMONIA ASPIRATION 127 0.0051
356 ALANINE AMINOTRANSFERASE INCREASED 312 0.0051
357 ROTATOR CUFF SYNDROME 65 0.0051
358 PERITONITIS BACTERIAL 51 0.0050
359 ATRIAL FIBRILLATION 488 0.0050
360 OSTEOPOROSIS 206 0.0050
361 DRUG TOXICITY 68 0.0050
362 CIRCULATORY COLLAPSE 85 0.0050
363 MATERNAL EXPOSURE BEFORE PREGNANCY 34 0.0050
364 BLOOD CREATINE PHOSPHOKINASE INCREASED 143 0.0050
365 ARTERIAL OCCLUSIVE DISEASE 39 0.0050
366 INTERNATIONAL NORMALISED RATIO INCREASED 141 0.0049
367 TACHYPNOEA 67 0.0049
368 PERIPHERAL SWELLING 757 0.0049
369 DECREASED ACTIVITY 53 0.0049
370 COVID-19 PNEUMONIA 58 0.0049
371 OVARIAN CYST 49 0.0049
372 SQUAMOUS CELL CARCINOMA 46 0.0049
373 MIDDLE INSOMNIA 91 0.0049
374 BURSITIS 59 0.0049
375 DIABETES MELLITUS 370 0.0048
376 CHEST PAIN 898 0.0048
377 BLOOD CHOLESTEROL INCREASED 226 0.0048
378 MUSCULOSKELETAL CHEST PAIN 75 0.0048
379 GINGIVAL BLEEDING 66 0.0048
380 BOWEL MOVEMENT IRREGULARITY 37 0.0048
381 ECCHYMOSIS 33 0.0048
382 HEMIPLEGIA 40 0.0048
383 SUPRAVENTRICULAR TACHYCARDIA 46 0.0048
384 FACE OEDEMA 81 0.0048
385 MYOSITIS 43 0.0048
386 GROIN PAIN 42 0.0048
387 C-REACTIVE PROTEIN INCREASED 174 0.0048
388 GINGIVAL PAIN 38 0.0048
389 PLATELET COUNT DECREASED 507 0.0048
390 PNEUMONIA 1538 0.0047
391 GASTROINTESTINAL HAEMORRHAGE 397 0.0047
392 BLOOD COUNT ABNORMAL 72 0.0047
393 ESCHERICHIA INFECTION 39 0.0047
394 MALNUTRITION 53 0.0047
395 LOWER GASTROINTESTINAL HAEMORRHAGE 35 0.0047
396 UPPER-AIRWAY COUGH SYNDROME 39 0.0047
397 FACIAL PAIN 42 0.0047
398 RED BLOOD CELL SEDIMENTATION RATE INCREASED 52 0.0047
399 MELAENA 103 0.0047
400 OBSTRUCTIVE AIRWAYS DISORDER 52 0.0047
401 THERAPY NON-RESPONDER 210 0.0047
402 HAEMORRHOIDS 91 0.0047
403 SKIN DISCOLOURATION 214 0.0047
404 PALPITATIONS 545 0.0046
405 ATAXIA 55 0.0046
406 HEART RATE INCREASED 459 0.0046
407 BACTERIAL INFECTION 86 0.0046
408 SPINAL COMPRESSION FRACTURE 38 0.0046
409 PRODUCT ADMINISTRATION INTERRUPTED 36 0.0046
410 CELLULITIS 231 0.0046
411 CYANOSIS 72 0.0046
412 LIMB INJURY 124 0.0046
413 RED BLOOD CELL COUNT DECREASED 130 0.0045
414 PERITONITIS 94 0.0045
415 PNEUMONITIS 123 0.0045
416 SYNCOPE 450 0.0045
417 PELVIC FRACTURE 35 0.0045
418 WEIGHT FLUCTUATION 47 0.0045
419 URINARY TRACT INFECTION 762 0.0045
420 EMPHYSEMA 45 0.0045
421 DYSURIA 164 0.0045
422 PLATELET COUNT INCREASED 58 0.0044
423 GASTRIC HAEMORRHAGE 51 0.0044
424 PSEUDOMONAS INFECTION 38 0.0044
425 DYSPNOEA 2507 0.0044
426 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 231 0.0044
427 RESPIRATORY DEPRESSION 54 0.0044
428 FAECES SOFT 32 0.0044
429 ARRHYTHMIA 208 0.0044
430 HAEMATEMESIS 111 0.0044
431 CONSTIPATION 954 0.0044
432 TEMPERATURE INTOLERANCE 45 0.0044
433 CHOLELITHIASIS 143 0.0044
434 BLOOD CALCIUM DECREASED 49 0.0044
435 CHEST DISCOMFORT 446 0.0044
436 HOSPICE CARE 43 0.0043
437 RESPIRATORY ARREST 120 0.0043
438 HYPERCHOLESTEROLAEMIA 42 0.0043
439 SUDDEN DEATH 46 0.0043
440 INFUSION SITE PAIN 56 0.0043
441 CYTOMEGALOVIRUS INFECTION 72 0.0043
442 ARTHRITIS 340 0.0043
443 TACHYCARDIA 384 0.0043
444 COAGULOPATHY 72 0.0043
445 PANCREATITIS ACUTE 97 0.0043
446 ELECTROCARDIOGRAM QT PROLONGED 155 0.0043
447 MULTIPLE ORGAN DYSFUNCTION SYNDROME 122 0.0043
448 CARDIO-RESPIRATORY ARREST 180 0.0043
449 COUGH 1207 0.0043
450 OESOPHAGITIS 47 0.0043
451 DECREASED APPETITE 996 0.0043
452 SEROTONIN SYNDROME 82 0.0043
453 NO THERAPEUTIC RESPONSE 52 0.0043
454 HAEMOLYTIC ANAEMIA 38 0.0042
455 SEPSIS 473 0.0042
456 DELIRIUM 147 0.0042
457 SKIN LESION 116 0.0042
458 PNEUMOTHORAX 67 0.0042
459 INTENTIONAL OVERDOSE 271 0.0042
460 BLOOD IRON DECREASED 50 0.0042
461 DERMATITIS CONTACT 48 0.0042
462 GAMMA-GLUTAMYLTRANSFERASE INCREASED 93 0.0042
463 HYPOPHAGIA 107 0.0042
464 MOUTH ULCERATION 88 0.0042
465 HALLUCINATION, VISUAL 88 0.0042
466 SWELLING 390 0.0042
467 MUSCULOSKELETAL PAIN 218 0.0042
468 HICCUPS 34 0.0041
469 CARPAL TUNNEL SYNDROME 58 0.0041
470 SUBDURAL HAEMATOMA 59 0.0041
471 SCAB 47 0.0041
472 DRUG-INDUCED LIVER INJURY 129 0.0041
473 EOSINOPHILIA 72 0.0041
474 IMPAIRED GASTRIC EMPTYING 56 0.0041
475 EPISTAXIS 307 0.0041
476 ORAL HERPES 80 0.0041
477 CATARACT 244 0.0041
478 ASTHENIA 1539 0.0041
479 PHARYNGEAL SWELLING 40 0.0041
480 CYSTITIS 130 0.0041
481 CEREBROVASCULAR ACCIDENT 691 0.0041
482 HYPOKINESIA 59 0.0041
483 CLOSTRIDIUM DIFFICILE COLITIS 43 0.0041
484 TOXICITY TO VARIOUS AGENTS 683 0.0040
485 LETHARGY 233 0.0040
486 BRONCHITIS 299 0.0040
487 LIVER DISORDER 179 0.0040
488 DYSPEPSIA 397 0.0040
489 FEELING COLD 112 0.0040
490 WEIGHT DECREASED 1122 0.0040
491 URINARY RETENTION 134 0.0040
492 SCAR 68 0.0040
493 NASAL CONGESTION 233 0.0040
494 EOSINOPHIL COUNT INCREASED 33 0.0040
495 ADRENAL INSUFFICIENCY 48 0.0040
496 SEPTIC SHOCK 172 0.0039
497 TYPE 2 DIABETES MELLITUS 133 0.0039
498 HAEMATOMA 102 0.0039
499 JOINT SWELLING 475 0.0039
500 INTERVERTEBRAL DISC PROTRUSION 86 0.0039
501 BLOOD GLUCOSE FLUCTUATION 43 0.0039
502 UNRESPONSIVE TO STIMULI 101 0.0039
503 ABDOMINAL PAIN 907 0.0039
504 GLAUCOMA 75 0.0039
505 FACIAL PARALYSIS 33 0.0039
506 SPINAL PAIN 45 0.0038
507 LOSS OF CONSCIOUSNESS 492 0.0038
508 INTESTINAL OBSTRUCTION 144 0.0038
509 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 89 0.0038
510 MYOCARDIAL INFARCTION 666 0.0038
511 ABDOMINAL DISTENSION 398 0.0038
512 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 209 0.0038
513 RETINAL DETACHMENT 35 0.0038
514 INCREASED TENDENCY TO BRUISE 35 0.0038
515 ORAL PAIN 85 0.0038
516 FALL 1260 0.0038
517 THERAPY PARTIAL RESPONDER 59 0.0038
518 HYPOTHERMIA 38 0.0037
519 LIVER FUNCTION TEST ABNORMAL 109 0.0037
520 TREATMENT NONCOMPLIANCE 205 0.0037
521 LIP DRY 34 0.0037
522 POISONING 47 0.0037
523 DISORIENTATION 148 0.0037
524 DRUG LEVEL DECREASED 38 0.0037
525 HERPES ZOSTER 214 0.0037
526 MUSCULAR WEAKNESS 423 0.0037
527 DYSARTHRIA 140 0.0037
528 MUSCULOSKELETAL DISCOMFORT 64 0.0037
529 DRUG INTOLERANCE 359 0.0037
530 SWOLLEN TONGUE 116 0.0037
531 GASTROENTERITIS VIRAL 67 0.0037
532 HEPATIC STEATOSIS 69 0.0037
533 BLOOD BILIRUBIN INCREASED 100 0.0037
534 DIZZINESS 1846 0.0037
535 CARDIOTOXICITY 33 0.0037
536 DIARRHOEA 2388 0.0037
537 TASTE DISORDER 75 0.0037
538 BACK PAIN 858 0.0037
539 VITAMIN D DEFICIENCY 36 0.0037
540 MYOCLONUS 44 0.0037
541 PANCYTOPENIA 205 0.0037
542 NEUROTOXICITY 64 0.0036
543 BODY HEIGHT DECREASED 39 0.0036
544 ERYTHEMA MULTIFORME 34 0.0036
545 ANGIOEDEMA 161 0.0036
546 HEPATOTOXICITY 81 0.0036
547 POLLAKIURIA 151 0.0036
548 PHARMACEUTICAL PRODUCT COMPLAINT 94 0.0036
549 KIDNEY INFECTION 71 0.0036
550 LUNG DISORDER 177 0.0036
551 DELUSION 56 0.0036
552 STEVENS-JOHNSON SYNDROME 80 0.0036
553 DYSPHONIA 210 0.0036
554 DRY MOUTH 291 0.0036
555 BALANCE DISORDER 310 0.0036
556 ISCHAEMIC STROKE 64 0.0036
557 RENAL PAIN 38 0.0036
558 MUSCULOSKELETAL STIFFNESS 314 0.0036
559 EATING DISORDER 76 0.0036
560 PAIN IN EXTREMITY 1051 0.0036
561 PALLOR 97 0.0036
562 INTESTINAL PERFORATION 40 0.0036
563 JOINT INJURY 76 0.0036
564 ANKLE FRACTURE 55 0.0035
565 ENCEPHALOPATHY 87 0.0035
566 SWELLING FACE 230 0.0035
567 FEAR 95 0.0035
568 NODULE 46 0.0035
569 FULL BLOOD COUNT DECREASED 71 0.0035
570 HIP FRACTURE 113 0.0035
571 SECRETION DISCHARGE 44 0.0035
572 CONTUSION 338 0.0035
573 RESPIRATORY TRACT INFECTION 91 0.0035
574 BRAIN OEDEMA 44 0.0035
575 RECTAL HAEMORRHAGE 149 0.0035
576 UPPER RESPIRATORY TRACT INFECTION 160 0.0035
577 FAECES DISCOLOURED 75 0.0035
578 GAIT DISTURBANCE 662 0.0035
579 ULCER 55 0.0035
580 MUSCLE SPASMS 631 0.0034
581 POST PROCEDURAL COMPLICATION 66 0.0034
582 BLADDER DISORDER 34 0.0034
583 EXTRAPYRAMIDAL DISORDER 85 0.0034
584 SPLENOMEGALY 40 0.0034
585 HEAD INJURY 108 0.0034
586 CHROMATURIA 77 0.0034
587 RIB FRACTURE 70 0.0034
588 COMA 162 0.0034
589 RESPIRATORY TRACT CONGESTION 54 0.0034
590 FEBRILE NEUTROPENIA 225 0.0034
591 SYSTEMIC LUPUS ERYTHEMATOSUS 120 0.0034
592 BREAST PAIN 36 0.0034
593 IMPAIRED WORK ABILITY 72 0.0034
594 THIRST 60 0.0034
595 DYSSTASIA 98 0.0034
596 COLON CANCER 50 0.0034
597 PETECHIAE 35 0.0034
598 HEADACHE 2101 0.0033
599 APHASIA 101 0.0033
600 POOR QUALITY SLEEP 72 0.0033
601 INJURY 235 0.0033
602 PROSTATIC SPECIFIC ANTIGEN INCREASED 46 0.0033
603 BODY TEMPERATURE INCREASED 68 0.0033
604 FLATULENCE 189 0.0033
605 INTENTIONAL DOSE OMISSION 95 0.0033
606 DEMENTIA 93 0.0033
607 FOOT FRACTURE 63 0.0033
608 BLOOD URINE PRESENT 63 0.0033
609 FLUSHING 337 0.0033
610 MOVEMENT DISORDER 106 0.0033
611 PRESYNCOPE 80 0.0033
612 HYPERBILIRUBINAEMIA 34 0.0033
613 ABASIA 81 0.0033
614 MOBILITY DECREASED 235 0.0033
615 EYELID OEDEMA 38 0.0033
616 MACULAR DEGENERATION 39 0.0033
617 HAEMOPTYSIS 91 0.0033
618 BLISTER 183 0.0033
619 DENTAL CARIES 36 0.0033
620 DEEP VEIN THROMBOSIS 211 0.0032
621 MICTURITION URGENCY 37 0.0032
622 ARTHROPATHY 180 0.0032
623 BONE DISORDER 59 0.0032
624 ABDOMINAL DISCOMFORT 543 0.0032
625 PHARYNGITIS 40 0.0032
626 MALAISE 1414 0.0032
627 CONFUSIONAL STATE 521 0.0032
628 INCONTINENCE 34 0.0032
629 STOMATITIS 195 0.0032
630 SKIN DISORDER 107 0.0032
631 SUICIDE ATTEMPT 194 0.0032
632 PANCREATITIS 169 0.0032
633 WOUND INFECTION 35 0.0032
634 CARDIAC DISORDER 299 0.0032
635 ORAL CANDIDIASIS 42 0.0032
636 PHARYNGEAL OEDEMA 49 0.0032
637 POST PROCEDURAL HAEMORRHAGE 37 0.0032
638 DIVERTICULITIS 88 0.0032
639 THROAT IRRITATION 142 0.0032
640 PYREXIA 1091 0.0031
641 ERUCTATION 61 0.0031
642 DYSPHAGIA 299 0.0031
643 DRY THROAT 32 0.0031
644 TOOTH DISORDER 70 0.0031
645 CONDITION AGGRAVATED 955 0.0031
646 HEPATIC ENZYME INCREASED 214 0.0031
647 INFLAMMATION 162 0.0031
648 AGEUSIA 78 0.0031
649 SKIN LACERATION 34 0.0031
650 DIABETIC KETOACIDOSIS 75 0.0031
651 SKIN INFECTION 35 0.0031
652 NERVOUSNESS 163 0.0031
653 PULMONARY THROMBOSIS 34 0.0031
654 MYELODYSPLASTIC SYNDROME 45 0.0031
655 FATIGUE 2421 0.0031
656 FEELING JITTERY 59 0.0031
657 VIRAL INFECTION 103 0.0031
658 SPEECH DISORDER 162 0.0031
659 LUNG INFECTION 48 0.0031
660 EJECTION FRACTION DECREASED 48 0.0031
661 INFLUENZA 343 0.0031
662 CARDIOVASCULAR DISORDER 78 0.0031
663 OROPHARYNGEAL PAIN 284 0.0031
664 BLINDNESS 125 0.0031
665 LIP SWELLING 102 0.0031
666 QUALITY OF LIFE DECREASED 41 0.0031
667 HAIR COLOUR CHANGES 38 0.0031
668 WHEEZING 181 0.0030
669 THYROID DISORDER 47 0.0030
670 NIGHT SWEATS 98 0.0030
671 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 146 0.0030
672 BACK INJURY 33 0.0030
673 OCULAR DISCOMFORT 34 0.0030
674 RESTLESS LEGS SYNDROME 55 0.0030
675 MYALGIA 514 0.0030
676 ABDOMINAL PAIN UPPER 622 0.0030
677 GASTROINTESTINAL DISORDER 270 0.0030
678 COORDINATION ABNORMAL 42 0.0030
679 DERMATITIS 63 0.0030
680 NECK PAIN 168 0.0030
681 MASS 42 0.0030
682 URINARY INCONTINENCE 89 0.0030
683 FEMUR FRACTURE 93 0.0030
684 NEURALGIA 73 0.0030
685 SPINAL FRACTURE 60 0.0030
686 INTENTIONAL PRODUCT USE ISSUE 262 0.0030
687 OSTEONECROSIS OF JAW 74 0.0030
688 RASH PRURITIC 162 0.0030
689 METASTASES TO BONE 49 0.0030
690 TINNITUS 137 0.0030
691 SINUS DISORDER 59 0.0030
692 BLINDNESS UNILATERAL 42 0.0030
693 RHEUMATOID ARTHRITIS 338 0.0030
694 RESPIRATORY DISORDER 89 0.0030
695 JAUNDICE 80 0.0030
696 VOMITING 1396 0.0030
697 NEUTROPHIL COUNT DECREASED 121 0.0030
698 HEPATIC FAILURE 89 0.0029
699 UNEVALUABLE EVENT 223 0.0029
700 INSOMNIA 785 0.0029
701 STAPHYLOCOCCAL INFECTION 97 0.0029
702 SINUSITIS 301 0.0029
703 NAUSEA 2320 0.0029
704 INFUSION RELATED REACTION 194 0.0029
705 ASPIRATION 32 0.0029
706 HYPOAESTHESIA 437 0.0029
707 RASH MACULAR 102 0.0029
708 BLOOD GLUCOSE DECREASED 140 0.0029
709 LACRIMATION INCREASED 88 0.0029
710 HEPATITIS 74 0.0029
711 DEPRESSION 658 0.0029
712 ERECTILE DYSFUNCTION 74 0.0029
713 ARTHRALGIA 1198 0.0029
714 PEMPHIGUS 36 0.0029
715 BLOOD GLUCOSE INCREASED 542 0.0029
716 BRAIN FOG 45 0.0029
717 WHITE BLOOD CELL COUNT DECREASED 311 0.0029
718 ANXIETY 816 0.0029
719 DEVICE RELATED INFECTION 44 0.0029
720 METASTASES TO LUNG 33 0.0029
721 EYE PAIN 161 0.0029
722 IRRITABLE BOWEL SYNDROME 61 0.0028
723 PARAESTHESIA 446 0.0028
724 HYPERTHYROIDISM 41 0.0028
725 PAIN 1739 0.0028
726 LYMPHADENOPATHY 100 0.0028
727 DYSGEUSIA 209 0.0028
728 FEEDING DISORDER 57 0.0028
729 THROMBOSIS 226 0.0028
730 GENERAL PHYSICAL HEALTH DETERIORATION 325 0.0028
731 HAEMORRHAGE INTRACRANIAL 42 0.0028
732 ANAPHYLACTIC REACTION 155 0.0028
733 TREMOR 465 0.0028
734 GALLBLADDER DISORDER 50 0.0028
735 INTERNAL HAEMORRHAGE 32 0.0028
736 TOOTH LOSS 58 0.0028
737 APHONIA 39 0.0028
738 THERAPEUTIC RESPONSE DECREASED 169 0.0028
739 WEIGHT INCREASED 623 0.0028
740 THROMBOCYTOPENIA 311 0.0028
741 CONVULSION 159 0.0028
742 TENDONITIS 43 0.0028
743 BLOOD TEST ABNORMAL 39 0.0028
744 BURNING SENSATION 194 0.0028
745 SOMNOLENCE 556 0.0028
746 NEUROPATHY PERIPHERAL 261 0.0027
747 CYST 34 0.0027
748 ASTHMA 309 0.0027
749 METASTASES TO LIVER 48 0.0027
750 PARALYSIS 39 0.0027
751 VERTIGO 166 0.0027
752 COLD SWEAT 48 0.0027
753 INCREASED APPETITE 52 0.0027
754 RETCHING 58 0.0027
755 HALLUCINATION 205 0.0027
756 MUSCLE TIGHTNESS 44 0.0027
757 LABORATORY TEST ABNORMAL 80 0.0027
758 RHINORRHOEA 175 0.0027
759 PRESCRIBED UNDERDOSE 54 0.0027
760 JOINT STIFFNESS 71 0.0027
761 LEUKOPENIA 135 0.0027
762 AGRANULOCYTOSIS 50 0.0027
763 PRURITUS GENERALISED 58 0.0027
764 DEAFNESS 70 0.0027
765 RASH PAPULAR 60 0.0027
766 DISEASE RECURRENCE 127 0.0027
767 PROCEDURAL PAIN 74 0.0027
768 BEDRIDDEN 35 0.0027
769 DYSKINESIA 108 0.0027
770 CLOSTRIDIUM DIFFICILE INFECTION 58 0.0027
771 NASOPHARYNGITIS 489 0.0027
772 DRY EYE 132 0.0026
773 VISION BLURRED 362 0.0026
774 PARAESTHESIA ORAL 38 0.0026
775 MEDICATION ERROR 146 0.0026
776 PRODUCT ADMINISTRATION ERROR 53 0.0026
777 TRANSAMINASES INCREASED 58 0.0026
778 RASH MACULO-PAPULAR 58 0.0026
779 NEPHROLITHIASIS 119 0.0026
780 LYMPHOMA 40 0.0026
781 COLITIS 98 0.0026
782 HYPERHIDROSIS 333 0.0026
783 EYE SWELLING 96 0.0026
784 WOUND 72 0.0026
785 CHILLS 301 0.0026
786 RASH GENERALISED 66 0.0025
787 CENTRAL NERVOUS SYSTEM LESION 35 0.0025
788 PREGNANCY 51 0.0025
789 EMOTIONAL DISTRESS 308 0.0025
790 HEAD DISCOMFORT 45 0.0025
791 BONE PAIN 148 0.0025
792 ACTIVITIES OF DAILY LIVING IMPAIRED 50 0.0025
793 LOCAL SWELLING 44 0.0025
794 MUSCULOSKELETAL DISORDER 48 0.0025
795 ORAL DISCOMFORT 35 0.0025
796 HALLUCINATION, AUDITORY 40 0.0025
797 HYPERSOMNIA 72 0.0025
798 ROAD TRAFFIC ACCIDENT 105 0.0025
799 SLEEP DISORDER 177 0.0025
800 GLOSSODYNIA 56 0.0025
801 PHOTOPHOBIA 47 0.0025
802 DRUG RESISTANCE 64 0.0025
803 PLASMA CELL MYELOMA 97 0.0025
804 OFF LABEL USE 2171 0.0025
805 EAR PAIN 48 0.0025
806 HAIR TEXTURE ABNORMAL 33 0.0025
807 HAEMATOCHEZIA 136 0.0025
808 INFECTION 356 0.0025
809 LOWER LIMB FRACTURE 47 0.0024
810 FRACTURE 46 0.0024
811 PRURITUS 931 0.0024
812 DRUG DISPENSING ERROR 37 0.0024
813 FEELING ABNORMAL 579 0.0024
814 RASH 1053 0.0024
815 PSYCHOMOTOR HYPERACTIVITY 40 0.0024
816 DISEASE PROGRESSION 285 0.0024
817 LIVER INJURY 59 0.0024
818 ERYTHEMA 494 0.0024
819 DIPLOPIA 62 0.0024
820 HOSPITALISATION 366 0.0024
821 FEELING HOT 146 0.0024
822 IMPAIRED HEALING 78 0.0024
823 LOWER RESPIRATORY TRACT INFECTION 108 0.0024
824 RASH ERYTHEMATOUS 113 0.0024
825 BONE MARROW FAILURE 48 0.0024
826 CHOKING 46 0.0024
827 HEPATIC CIRRHOSIS 44 0.0023
828 PRODUCT DOSE OMISSION 152 0.0023
829 SKIN CANCER 50 0.0023
830 AMNESIA 151 0.0023
831 SEIZURE 267 0.0023
832 EYE DISORDER 76 0.0023
833 UPPER LIMB FRACTURE 46 0.0023
834 COVID-19 405 0.0023
835 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 59 0.0023
836 THROAT TIGHTNESS 62 0.0023
837 INSURANCE ISSUE 35 0.0023
838 IMMUNODEFICIENCY 34 0.0023
839 HAEMORRHAGE 238 0.0023
840 GASTRIC DISORDER 78 0.0023
841 HOT FLUSH 171 0.0023
842 FIBROMYALGIA 55 0.0023
843 HYPOACUSIS 97 0.0023
844 CANDIDA INFECTION 38 0.0022
845 VISUAL IMPAIRMENT 278 0.0022
846 MENTAL IMPAIRMENT 54 0.0022
847 MIGRAINE 212 0.0022
848 ABDOMINAL PAIN LOWER 56 0.0022
849 RESTLESSNESS 81 0.0022
850 PERICARDITIS 37 0.0022
851 ABSCESS 35 0.0022
852 MALIGNANT NEOPLASM PROGRESSION 224 0.0022
853 ACCIDENTAL OVERDOSE 80 0.0022
854 MEMORY IMPAIRMENT 300 0.0022
855 PRESCRIBED OVERDOSE 42 0.0022
856 SKIN EXFOLIATION 183 0.0022
857 VISUAL ACUITY REDUCED 72 0.0022
858 BLOOD GLUCOSE ABNORMAL 40 0.0022
859 FUNGAL INFECTION 72 0.0022
860 PULMONARY EMBOLISM 205 0.0022
861 ILL-DEFINED DISORDER 131 0.0022
862 SNEEZING 48 0.0021
863 HYPERSENSITIVITY 395 0.0021
864 EPILEPSY 65 0.0021
865 TREATMENT FAILURE 176 0.0021
866 PRODUCT DOSE OMISSION IN ERROR 60 0.0021
867 PRODUCT USE IN UNAPPROVED INDICATION 522 0.0021
868 TOOTHACHE 38 0.0021
869 ABORTION SPONTANEOUS 84 0.0021
870 GAIT INABILITY 70 0.0021
871 NERVOUS SYSTEM DISORDER 65 0.0021
872 MUSCLE TWITCHING 48 0.0021
873 LIMB DISCOMFORT 64 0.0021
874 THERAPY CESSATION 106 0.0021
875 GLYCOSYLATED HAEMOGLOBIN INCREASED 52 0.0021
876 PRODUCT PRESCRIBING ERROR 49 0.0021
877 CONJUNCTIVITIS 38 0.0020
878 FREQUENT BOWEL MOVEMENTS 55 0.0020
879 PANIC ATTACK 74 0.0020
880 BACK DISORDER 33 0.0020
881 NIGHTMARE 70 0.0020
882 DEPRESSED MOOD 106 0.0020
883 DRUG INEFFECTIVE 2641 0.0020
884 DISCOMFORT 122 0.0020
885 OVERDOSE 429 0.0020
886 AGITATION 146 0.0020
887 AGGRESSION 99 0.0020
888 HERNIA 38 0.0020
889 THERAPY INTERRUPTED 140 0.0020
890 EAR INFECTION 52 0.0020
891 EMOTIONAL DISORDER 60 0.0019
892 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 349 0.0019
893 DRUG EFFECT DECREASED 104 0.0019
894 PRODUCT SUBSTITUTION ISSUE 111 0.0019
895 ABNORMAL DREAMS 53 0.0019
896 LIVER FUNCTION TEST INCREASED 41 0.0019
897 MENTAL DISORDER 83 0.0019
898 THERAPEUTIC RESPONSE SHORTENED 62 0.0019
899 PSYCHOTIC DISORDER 55 0.0019
900 SURGERY 109 0.0019
901 ILLNESS 191 0.0019
902 KNEE ARTHROPLASTY 39 0.0019
903 BONE DENSITY DECREASED 58 0.0018
904 ECZEMA 96 0.0018
905 PRODUCT PHYSICAL ISSUE 37 0.0018
906 SEDATION 48 0.0018
907 THERAPEUTIC RESPONSE UNEXPECTED 82 0.0018
908 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 130 0.0018
909 PRODUCT USE ISSUE 343 0.0018
910 DRUG PRESCRIBING ERROR 35 0.0018
911 DEATH 1565 0.0018
912 CYTOKINE RELEASE SYNDROME 36 0.0018
913 THERAPEUTIC PRODUCT EFFECT DECREASED 80 0.0018
914 ANAPHYLACTIC SHOCK 46 0.0018
915 CHOLESTASIS 34 0.0018
916 INFLUENZA LIKE ILLNESS 144 0.0017
917 PAIN OF SKIN 46 0.0017
918 SKIN FISSURES 33 0.0017
919 EYE IRRITATION 97 0.0017
920 PRODUCT DOSE OMISSION ISSUE 495 0.0017
921 DISABILITY 33 0.0017
922 NEOPLASM PROGRESSION 58 0.0017
923 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 118 0.0017
924 ALOPECIA 322 0.0016
925 VAGINAL HAEMORRHAGE 71 0.0016
926 INTENTIONAL DRUG MISUSE 34 0.0016
927 PSORIATIC ARTHROPATHY 66 0.0016
928 OCULAR HYPERAEMIA 76 0.0016
929 URTICARIA 268 0.0016
930 DRY SKIN 213 0.0016
931 DRUG DOSE OMISSION 262 0.0016
932 EYE PRURITUS 53 0.0016
933 NEUTROPENIA 212 0.0016
934 DISTURBANCE IN ATTENTION 84 0.0016
935 WRONG TECHNIQUE IN DRUG USAGE PROCESS 56 0.0015
936 PRODUCT PRESCRIBING ISSUE 33 0.0015
937 PRODUCT AVAILABILITY ISSUE 34 0.0015
938 ABNORMAL BEHAVIOUR 59 0.0015
939 INTENTIONAL PRODUCT MISUSE 129 0.0015
940 MOOD ALTERED 40 0.0015
941 SUICIDAL IDEATION 134 0.0015
942 CRYING 53 0.0015
943 IRRITABILITY 87 0.0014
944 NEEDLE ISSUE 42 0.0014
945 OSTEONECROSIS 47 0.0014
946 NEOPLASM MALIGNANT 95 0.0014
947 GASTRIC CANCER 36 0.0014
948 MYELOSUPPRESSION 51 0.0014
949 INJECTION SITE MASS 52 0.0014
950 WITHDRAWAL SYNDROME 56 0.0013
951 COGNITIVE DISORDER 61 0.0013
952 PRODUCT COMPLAINT 33 0.0013
953 ADVERSE EVENT 120 0.0013
954 DRUG EFFECT INCOMPLETE 47 0.0013
955 LUNG NEOPLASM MALIGNANT 52 0.0013
956 DEVICE DISLOCATION 55 0.0013
957 COLITIS ULCERATIVE 56 0.0013
958 INCORRECT DRUG ADMINISTRATION DURATION 35 0.0012
959 PRODUCT QUALITY ISSUE 169 0.0012
960 INCORRECT DOSE ADMINISTERED 279 0.0012
961 INJECTION SITE SWELLING 90 0.0012
962 GYNAECOMASTIA 36 0.0012
963 INJECTION SITE HAEMORRHAGE 91 0.0011
964 MOOD SWINGS 36 0.0011
965 ADVERSE DRUG REACTION 101 0.0011
966 DERMATITIS ATOPIC 59 0.0011
967 INJECTION SITE RASH 34 0.0011
968 EXPIRED PRODUCT ADMINISTERED 35 0.0011
969 INJECTION SITE BRUISING 84 0.0011
970 PSORIASIS 137 0.0010
971 DRUG ADMINISTRATION ERROR 32 0.0010
972 UNDERDOSE 76 0.0010
973 ANGER 35 0.0010
974 INJECTION SITE PRURITUS 68 0.0010
975 INJECTION SITE PAIN 298 0.0010
976 PROSTATE CANCER 77 0.0010
977 ACNE 72 0.0009
978 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 184 0.0009
979 DEVICE ISSUE 81 0.0009
980 SKIN IRRITATION 41 0.0009
981 INJECTION SITE ERYTHEMA 105 0.0008
982 NO ADVERSE EVENT 152 0.0008
983 BREAST CANCER 78 0.0008
984 INJECTION SITE REACTION 56 0.0008
985 DEVICE MALFUNCTION 57 0.0008
986 MULTIPLE SCLEROSIS RELAPSE 54 0.0008
987 MULTIPLE SCLEROSIS 34 0.0007
988 BLADDER CANCER 37 0.0006
989 SKIN BURNING SENSATION 42 0.0006
990 ACCIDENTAL EXPOSURE TO PRODUCT 59 0.0006
991 DRUG WITHDRAWAL SYNDROME 49 0.0006
992 DEVICE DIFFICULT TO USE 34 0.0005
993 DRUG ABUSE 40 0.0005
994 DRUG DEPENDENCE 40 0.0002